{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T17:51:52Z","timestamp":1772992312867,"version":"3.50.1"},"reference-count":10,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":323,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Case Reports in Endocrinology"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:p>Lorlatinib, a tyrosine kinase inhibitor used in anaplastic lymphoma kinase (ALK)\u2010positive non\u2010small cell lung cancer (NSCLC), is associated with adverse events, including hyperglycemia. We present a case of a 52\u2010year\u2010old male with stage IV NSCLC and brain metastases who developed diabetic ketoacidosis (DKA) following lorlatinib initiation. The patient, without prior diabetes, presented with hyperglycemia (792\u2009mg\/dL), metabolic acidosis, and ketonuria 2 months after starting lorlatinib. He was treated for DKA and subsequently transitioned to a basal\u2010bolus insulin regimen. Lorlatinib was withheld transiently and restarted once acute symptoms resolved. This case, along with three reported cases of lorlatinib\u2010induced hyperglycemia, highlights a rare but serious potential complication. The mechanism of lorlatinib\u2010induced hyperglycemia is unclear but may involve reduced insulin secretion. This case underscores the importance of monitoring for hyperglycemia in patients receiving lorlatinib, even in the absence of pre\u2010existing diabetes, to enable early detection and prevent life\u2010threatening complications like DKA.<\/jats:p>","DOI":"10.1155\/crie\/8034190","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T11:23:07Z","timestamp":1763637787000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["New\u2010Onset Autoantibody\u2010Negative Diabetes With DKA Following Lorlatinib Therapy for ALK\u2010Positive NSCLC"],"prefix":"10.1155","volume":"2025","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5745-0112","authenticated-orcid":false,"given":"Ashni","family":"Dharia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4632-8030","authenticated-orcid":false,"given":"Anna","family":"Pleet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9826-5341","authenticated-orcid":false,"given":"Brittany","family":"West","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8907-269X","authenticated-orcid":false,"given":"Gayatri","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"e_1_2_10_1_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00444-8"},{"key":"e_1_2_10_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2025.01.010"},{"key":"e_1_2_10_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2025.04.015"},{"key":"e_1_2_10_4_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.00581"},{"key":"e_1_2_10_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-023-00449-x"},{"key":"e_1_2_10_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.5283"},{"key":"e_1_2_10_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2023.03.013"},{"key":"e_1_2_10_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2027187"},{"key":"e_1_2_10_9_2","unstructured":"\"Lorbrena (lorlatinib) [package Insert]. Pfizer 2021 [Online]. Availablehttps:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/210868s003lbl.pdf."},{"key":"e_1_2_10_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102653"}],"container-title":["Case Reports in Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/crie\/8034190","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1155\/crie\/8034190","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/crie\/8034190","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T13:51:08Z","timestamp":1772977868000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/crie\/8034190"}},"subtitle":[],"editor":[{"given":"Osamu","family":"Isozaki","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1155\/crie\/8034190"],"URL":"https:\/\/doi.org\/10.1155\/crie\/8034190","archive":["Portico"],"relation":{},"ISSN":["2090-6501","2090-651X"],"issn-type":[{"value":"2090-6501","type":"print"},{"value":"2090-651X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"2025-07-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"8034190"}}